Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Link between widely used osteoporosis drugs and heart problems probed

New research at Wake Forest University School of Medicine evaluated the link between a common class of drugs used to prevent bone fractures in osteoporosis patients and the development of irregular heartbeat.

6 Apr 2009

Your smile may be connected to your overall health

Scientists at the 87th General Session of the International Association for Dental Research, convening today in Miami Beach, report new studies on the connection between oral disease and systemic disease.

6 Apr 2009

Breakthrough for hypertension treatment

A world-first breakthrough to treat high blood pressure has been successfully trialled in Melbourne.

6 Apr 2009

NIH Nanotechnology Task Force and the NIH Nanomedicine Roadmap initiative host NanoWeek 2009

The NIH Nanotechnology Task Force and the NIH Nanomedicine Roadmap Initiative will host NanoWeek 2009 from Tuesday, April 7 through Friday, April 10 at the Natcher Conference Center on the NIH campus in Bethesda, Md. NIH's first-of-a-kind series of events focusing on science at the nanoscale, NanoWeek 2009 will include symposia with experts in the field, demonstrations, talks, and posters from NIH scientists.

4 Apr 2009

Study looks at long-term benefits of the Wingspan stent

Rush University Medical Center is participating in a National Institutes of Health (NIH) study to determine the best course of treatment to reduce the risk of stroke patients suffering another stroke.

2 Apr 2009

What makes olive oil so healthy?

Scientists have pinned down the constituent of olive oil that gives greatest protection from heart attack and stroke.

1 Apr 2009

Brain vessel malformations - intervention or a hands-off approach?

Individuals diagnosed with a brain arteriovenous malformation (BAVM) -- an abnormal tangle of arteries and veins -- are at increased risk of vessel rupture and bleeding that can cause permanent brain damage.

1 Apr 2009

New streamlined triage system for "brain attack"

Taking a page out of the playbook developed by cardiologists nearly two decades ago to promote the warning signs and swift treatment for heart attacks, a multidisciplinary team of stroke experts at the University of Rochester Medical Center (URMC) have created a new streamlined triage system at Strong Memorial Hospital's Emergency Department (ED) to provide rapid evaluation and specialized treatments to "brain attack," or stroke, patients.

1 Apr 2009

Addressing sleep problems could reduce the risk of suicidal behaviours

In a study presented at the World Psychiatric Association international congress "Treatments in Psychiatry," scientists found that the more types of sleep disturbances people had, the more likely they were to have thoughts of killing themselves, engage in planning a suicidal act or make a suicide attempt.

1 Apr 2009

Rigorous visual training helps the brain to see again after stroke

By doing a set of vigorous visual exercises on a computer every day for several months, patients who had gone partially blind as a result of suffering a stroke were able to regain some vision, according to scientists who published their results in the April 1 issue of the Journal of Neuroscience.

1 Apr 2009

By shutting down inflammation, agent reverses damage from spinal cord injury in preclinical studies

Researchers at Georgetown University Medical Center (GUMC) have been able to speed recovery and substantially reduce damage resulting from spinal cord injury in preclinical studies.

1 Apr 2009

NTRILIPIX (fenofibric acid) in combo with Rosuvastatin calcium shows improvement on key lipids for cholesterol management

Data from a new study showed that Abbott's TRILIPIX (fenofibric acid) delayed-release capsules in combination with rosuvastatin calcium met all of the study's primary endpoints.

29 Mar 2009

Drug-eluting stents found to be safer and superior to bare metal stents

Drug-eluting stents were safe and superior to bare metal stents in preventing death and heart attacks among 262,700 "real-world" patients enrolled in a nationwide registry of cardiovascular disease, according to researchers from Duke University Medical Center.

29 Mar 2009

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.

29 Mar 2009

CRESTOR found to reduced CV risk in patients achieving low LDL-C and hsCRP targets in new Jupiter analysis

Results from a new sub-analysis of the JUPITER study show that patients who attained a dual treatment target of LDL-C <70mg/dL and high-sensitivity C-reactive protein (hsCRP) <2mg/L with CRESTOR (rosuvastatin) 20mg achieved a greater reduction in cardiovascular events compared to placebo than those who did not (65% vs 36%, p=0.033) among men and women with low to normal cholesterol levels and elevated hsCRP.

29 Mar 2009

CRESTOR (rosuvastatin) shown to significantly reduce risk of venous thromboembolism

A new analysis from the JUPITER study shows that CRESTOR (rosuvastatin) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p=0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein (hsCRP).

29 Mar 2009

Amicus Therapeutics presents positive results from phase 2 extension study of Amigal for Fabry disease

Amicus Therapeutics has announced positive results from its ongoing Phase 2 extension study of its investigational drug, Amigal (migalastat HCL) for Fabry disease.

29 Mar 2009

Using public transit may help you keep fit

The study, published in the Journal of Public Health Policy, finds that people who take public transit are three times more likely than those who don't to meet the Heart and Stroke Foundation of Canada's suggested daily minimum of physical activity.

29 Mar 2009

Protein from tick saliva shows potential for myasthenia gravis treatment

Looking for a better treatment for the autoimmune disease myasthenia gravis, researchers have found that a protein in tick saliva shows promise in limiting the severity of the disease in an animal model in a study published in the Annals of Neurology.

29 Mar 2009

Transdermal delivery of estrogen therapy may show safety benefits as opposed to oral delivery

Transdermal delivery of estrogen therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to oral delivery, a new study suggests.

29 Mar 2009

Stroke News and Research

Further Reading

Link between widely used osteoporosis drugs and heart problems probed

Your smile may be connected to your overall health

Breakthrough for hypertension treatment

NIH Nanotechnology Task Force and the NIH Nanomedicine Roadmap initiative host NanoWeek 2009

Study looks at long-term benefits of the Wingspan stent

What makes olive oil so healthy?

Brain vessel malformations - intervention or a hands-off approach?

New streamlined triage system for "brain attack"

Addressing sleep problems could reduce the risk of suicidal behaviours

Rigorous visual training helps the brain to see again after stroke

By shutting down inflammation, agent reverses damage from spinal cord injury in preclinical studies

NTRILIPIX (fenofibric acid) in combo with Rosuvastatin calcium shows improvement on key lipids for cholesterol management

Drug-eluting stents found to be safer and superior to bare metal stents

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

CRESTOR found to reduced CV risk in patients achieving low LDL-C and hsCRP targets in new Jupiter analysis

CRESTOR (rosuvastatin) shown to significantly reduce risk of venous thromboembolism

Amicus Therapeutics presents positive results from phase 2 extension study of Amigal for Fabry disease

Using public transit may help you keep fit

Protein from tick saliva shows potential for myasthenia gravis treatment

Transdermal delivery of estrogen therapy may show safety benefits as opposed to oral delivery

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News